Clinical Trials Browser

Phase 2 × Advanced Lung Cancer × toripalimab × Clear all

NCT07309276 2025-12-30

A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer

Phase 2 Not yet recruiting

Advanced Lung Cancer